DTX Exchange (DTX) is preparing to launch its highly awaited listing in the next 60 days. Large investor and analyst ...

Historically, investing in early-stage tokens has provided the most returns to crypto investors. It is not uncommon for ...

APPS's bull thesis hinges on stabilizing ODS and growing the advertisement segment, leveraging high gross margins in DTX despite lower R&D investments. APPS's shift from waterfall to SDK bidding ...

Digital health company Better Therapeutics has submitted its lead prescription digital therapeutic (DTx) BT-001 to the FDA, seeking approval for use by adults with type 2 diabetes (T2D).